The Evolution of Virtual Care in Respirology

By Staff Writer

September 13, 2023

The escalating prevalence of chronic diseases coupled with an ageing population is leading to a significant surge in demand for continuous home and institutional care. With professional resources in Québec becoming increasingly limited, virtual care tools have emerged as a crucial solution to ensure access to care and services.

The COVID-19 pandemic has accelerated the use of virtual care tools, promoting continuity of care when in-person visits became risky or impossible. These tools, ranging from telemonitoring to teleconsultation, are becoming integral to the evaluation, treatment, and follow-up of patients in specialty medicine, including respirology.

Virtual Care Modalities in Respirology

Primarily, virtual care modalities are being used to improve access to health care and foster patient engagement in managing their illness. For instance, telemonitoring is the most studied intervention in all the care pathways examined, with a positive impact reported in patients with COPD (Chronic Obstructive Pulmonary Disease) and asthma. Telemonitoring, the most studied intervention, has shown positive effects in COPD and asthma patients. 


The potential of virtual care is vast. It can reduce symptoms of disease, decrease anxiety, improve disease management, and enhance the quality of life for patients. Furthermore, it can support primary care physicians in diagnosing diseases like COPD and asthma, thereby preventing misdiagnosis.

Challenges and Future Directions

Despite the promising results, there is a need for more high-quality studies to further explore the efficacy of virtual care interventions. Areas that need further investigation include the long-term efficacy of virtual care in terms of medication adherence and the use of virtual care for diseases like cystic fibrosis and chronic respiratory failure.

In conclusion, the most studied care pathway for the use of virtual care in respirology is for COPD, with telemonitoring being the most frequently used modality. As we continue to navigate the digital health landscape, the revolution of the respirology field is set to occur through the integration of virtual care modalities into care pathways.

Reference url

Recent Posts

biosimilar clinical approach
    

Biosimilar Clinical Approach

🚀 How is the EMA’s new biosimilar clinical approach changing the landscape of drug approvals in Europe?

With a focus on tailored clinical assessments, the EMA is streamlining the pathway for biosimilars by allowing analytical data to take precedence over large-scale comparative efficacy studies. This shift promises to enhance patient access to life-saving therapies while maintaining rigorous safety standards.

Dive deeper into the implications of this innovative regulatory approach and find out how it can impact health economics and market access.

👉 Read more in the full article!
#SyenzaNews #regulatoryaffairs #MarketAccess

HIV prevention injection
   

FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Prevention

🌍 Will Yeztugo Approval and Access Strategy Deliver an Inflection Point in HIV/AIDS?

Yeztugo (lenacapavir), a twice-yearly injection, redefines long-acting HIV prevention with 96–100% efficacy. Gilead’s access strategy—insurance, assistance, and generics for 120 countries—targets global impact. Can it balance $28,218 U.S. costs with equity for 1.3M annual infections? My article explores health economics, public health, and market dynamics.

📖 Read how Yeztugo’s access strategy could transform long-acting HIV prevention

#SyenzaNews #GlobalHealth #HIVPrevention #Yeztugo #PrEP

essential prescription drugs
       

Canada Launches Consultation for Essential Prescription Drugs List

💊 Are you curious about how Canada plans to make essential prescription drugs accessible for everyone?

Canada’s Drug Agency has launched a national consultation to create a list of essential prescriptions that aim to ensure equitable access, improve health outcomes, and reduce costs. This initiative marks a key step towards universal pharmacare and highlights the importance of evidence-based practices in healthcare.

Dive into our latest article to learn more about the implications for patients, policymakers, and the broader healthcare system!

#SyenzaNews #healthcare #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.